(Q42493683)

1 November 2017

title

Celecoxib inactivates epithelial-mesenchymal transition stimulated by hypoxia and/or epidermal growth factor in colon cancer cells (English)

1 reference

1 November 2017

1 reference

4

1 reference

1 November 2017

Claudia Bocca

1

1 reference

1 November 2017

Francesca Bozzo

series ordinal

2

1 reference

1 November 2017

Stefania Cannito

series ordinal

3

1 reference

1 November 2017

Antonella Miglietta

series ordinal

5

1 reference

1 November 2017

publication date

31 August 2011

1 reference

1 November 2017

published in

Molecular Carcinogenesis

1 reference

1 November 2017

volume

51

1 reference

1 November 2017

issue

10

1 reference

1 November 2017

page(s)

783-795

1 reference

Epidemiology of colorectal liver metastases.

1 November 2017

cites work

1 reference

Transcriptional regulation of cadherins during development and carcinogenesis.

21 January 2018

1 reference

Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells

21 January 2018

1 reference

Activation of beta-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis.

21 January 2018

1 reference

Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis

21 January 2018

1 reference

Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression

21 January 2018

1 reference

Convergence between Wnt-β-catenin and EGFR signaling in cancer

21 January 2018

1 reference

Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion.

21 January 2018

1 reference

Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression.

21 January 2018

1 reference

Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor

21 January 2018

1 reference

The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2

21 January 2018

1 reference

The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment

21 January 2018

1 reference

PGE2 inhibits apoptosis in human adenocarcinoma Caco-2 cell line through Ras-PI3K association and cAMP-dependent kinase A activation

21 January 2018

1 reference

Colon carcinoma cell growth is associated with prostaglandin E2/EP4 receptor-evoked ERK activation.

21 January 2018

1 reference

Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis.

21 January 2018

1 reference

Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy

21 January 2018

1 reference

Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer.

21 January 2018

1 reference

COX-2: a molecular target for colorectal cancer prevention

21 January 2018

1 reference

Prostaglandins and cancer

21 January 2018

1 reference

Direct non-cyclooxygenase-2 targets of celecoxib and their potential relevance for cancer therapy

21 January 2018

1 reference

Novel nitro-oxy derivatives of celecoxib for the regulation of colon cancer cell growth

21 January 2018

1 reference

Signaling through the epidermal growth factor receptor during the development of malignancy

21 January 2018

1 reference

Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung

21 January 2018

1 reference

The safety and efficacy of celecoxib in children with familial adenomatous polyposis

21 January 2018

1 reference

Persistent cyclooxygenase-2 inhibition downregulates NF-{kappa}B, resulting in chronic intestinal inflammation in the min/+ mouse model of colon tumorigenesis

21 January 2018

1 reference

Ang II and EGF synergistically induce COX-2 expression via CREB in intestinal epithelial cells

21 January 2018

1 reference

Cyclooxygenase-2 expression is an independent predictor of poor prognosis in colon cancer

21 January 2018

1 reference

Cyclooxygenase-2 promotes angiogenesis by increasing vascular endothelial growth factor and predicts prognosis in gallbladder carcinoma

21 January 2018

1 reference

(-)-Epigallocatechin gallate downregulates EGF receptor via phosphorylation at Ser1046/1047 by p38 MAPK in colon cancer cells

21 January 2018

1 reference

Tephrosin induces internalization and degradation of EGFR and ErbB2 in HT-29 human colon cancer cells.

21 January 2018

1 reference

Molecular pathways regulating EGF-induced epithelio-mesenchymal transition in human ovarian surface epithelium

21 January 2018

1 reference

Negative regulation of EGFR-Vav2 signaling axis by Cbl ubiquitin ligase controls EGF receptor-mediated epithelial cell adherens junction dynamics and cell migration.

21 January 2018

1 reference

Crosstalk of EGF-directed MAPK signalling pathways and its potential role on EGF-induced cell proliferation and COX-2 expression in human mesenchymal stem cells.

21 January 2018

1 reference

Epidermal growth factor receptor targeting in cancer

21 January 2018

1 reference

Hypoxia-independent overexpression of hypoxia-inducible factor 1alpha as an early change in mouse hepatocarcinogenesis

21 January 2018

1 reference

Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression

21 January 2018

1 reference

The PKB/AKT pathway in cancer

21 January 2018

1 reference

Cadherins and cancer: how does cadherin dysfunction promote tumor progression?

21 January 2018

1 reference

Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells

21 January 2018

1 reference

Epithelial-mesenchymal transition and the invasive potential of tumors.

21 January 2018

1 reference

Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front

21 January 2018

1 reference

Interaction between beta-catenin and HIF-1 promotes cellular adaptation to hypoxia

21 January 2018

1 reference

HIF-2alpha enhances beta-catenin/TCF-driven transcription by interacting with beta-catenin

21 January 2018

1 reference

uPAR induces epithelial-mesenchymal transition in hypoxic breast cancer cells

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MC.20846

1 reference

1 November 2017

1 reference